August 01, 2025 a 03:43 pm
ZBH: Fundamental Ratio Analysis - Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. operates in the expansive field of musculoskeletal healthcare, offering a vast range of products that cater to orthopedic surgeons and healthcare organizations worldwide. The stock appears to hold promise with a consistent sector demand and a broad global presence. Investment considerations should take into account the company's strategic market positions and external economic factors impacting the healthcare industry.
Fundamental Rating
The fundamental analysis shows a balanced score favoring discounted cash flow valuation and asset returns.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return On Equity | 3 | |
| Return On Assets | 4 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 3 |
Historical Rating
The historical scores reflect Zimmer Biomet's steady performance metrics over the recent past.
| Date | Overall | Discounted Cash Flow | Return On Equity | Return On Assets | Debt To Equity | Price To Earnings | Price To Book |
|---|---|---|---|---|---|---|---|
| 2025-07-31 | 3 | 5 | 3 | 4 | 1 | 2 | 3 |
| Previous | 0 | 5 | 3 | 4 | 1 | 2 | 3 |
Analyst Price Targets
Analysts offer a modestly optimistic view with a buy consensus, indicating a potential price appreciation.
| High | Low | Median | Consensus |
|---|---|---|---|
| $115 | $98 | $106.5 | $106.5 |
Analyst Sentiment
The broad analyst sentiment is positive, supporting a predominantly buy recommendation strategy.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 20 | |
| Hold | 18 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Zimmer Biomet Holdings, Inc. remains a strong player in the medical devices sector with robust product offerings. While its fundamental and historical ratings suggest stable performance, investors should remain vigilant regarding external economic conditions. Analyst sentiment and price targets imply potential growth, yet careful monitoring of healthcare policy changes is advisable. For long-term investors, ZBH represents a compelling opportunity amidst industry advancements. Nonetheless, active monitoring and risk assessment are paramount to leverage market dynamics effectively.